KUROS BIOSCIENCES

kuros-biosciences-logo

Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off of the Eidgenรถssische Technische Hochschule Zรผrich (ETHZ), Kuros has developed a pipeline of products based upon its proprietary technology platforms. These platforms were developed from work carried out at ETHZ, at the University of Zรผrich and at the California Institute of Technology (CalTech). In addition, in early 2017 Kuros acq... uired Xpand Biotechnology to gain access to its MagnetOs family of bone graft substitutes and the associated surface science technology. Kuros has attractive commercial prospects in key market segments as well as an EU hub for future clinical and distribution operations. The company is in transition to commercial stage with one product having marketing approval in the EU and US and further product expected to achieve EU approval this year. MagnetOs is approved for sale in the EU for orthopedic, spine and dental applications, and in the US for posterolateral spinal fusion. In addition, a putty formulation is being prepared for submission in the EU and the US in the second half of this year. Neuroseal, a novel biomaterial for dural sealing, is Kurosโ€™ second product and currently under review for CE marking in the EU. Kuros has also assembled a pipeline of clinical stage programs in various stages of development and amassed significant clinical and preclinical data in a number of indications and applications primarily in the area of orthobiologics. The Company has enrolled over 600 patients in multinational clinical trials, and has generated promising safety and efficacy in a number of significant indications.

#SimilarOrganizations #People #Financial #Website #More

KUROS BIOSCIENCES

Industry:
Biopharma Biotechnology Health Care Medical

Founded:
2000-01-01

Address:
Schlieren, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.kuros.ch

Total Employee:
11+

Status:
Active

Contact:
41 44 200 56 00

Email Addresses:
[email protected]

Total Funding:
70.93 M USD

Technology used in webpage:
SPF Mobile Non Scaleable Content Hostpoint DNS EUKHost


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

cequr-logo

CeQur

CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

eucodis-bioscience-logo

EUCODIS Bioscience

EUCODIS Bioscience delivered high-performance enzyme solutions for applications in the chemical, cosmetics and pharmaceutical industries.

expres2ion-logo

ExpreS2ion

ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.

kinarus-therapeutics-sixknrs-logo

Kinarus Therapeutics (SIX:KNRS)

Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.

lineage-cell-therapeutics-logo

Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.

pharma-biozyme-lab-logo

Pharma Biozyme Lab

Pharma Biozyme Lab develops products that contribute to the decontamination and detoxification of the body.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

rolf-zinkernagel_image

Rolf Zinkernagel Board of Directors @ Kuros Biosciences
Board_member

claudio-nessi_image

Claudio Nessi Board Member @ Kuros Biosciences
Board_member

dominik-ellenrieder_image

Dominik Ellenrieder Board Member @ Kuros Biosciences
Board_member

kurt-von-emster_image

Kurt von Emster Board of Directors @ Kuros Biosciences
Board_member

Current Employees Featured

not_available_image

Fritz Kunz
Fritz Kunz Chairman @ Kuros Biosciences
Chairman

not_available_image

Didier Cowling
Didier Cowling CEO @ Kuros Biosciences
CEO

kyle-altier_image

Kyle Altier
Kyle Altier Regional Sales Manager at Kuros Biosciences @ Kuros Biosciences
Regional Sales Manager at Kuros Biosciences
2022-02-01

jeffrey-a-hubbell_image

Jeffrey A. Hubbell
Jeffrey A. Hubbell Founder @ Kuros Biosciences
Founder

not_available_image

Jason Schense
Jason Schense CTO @ Kuros Biosciences
CTO

Founder


jeffrey-a-hubbell_image

Jeffrey A. Hubbell

Stock Details


Company's stock symbol is SWX:KURN

Acquisitions List

Date Company Article Price
2016-12-19 Xpand Biotechnology Xpand Biotechnology acquired by Kuros Biosciences N/A

Investors List

lifecare-partners_image

LifeCare Partners

LifeCare Partners investment in Post-IPO Equity - Kuros Biosciences

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Post-IPO Equity - Kuros Biosciences

vi-partners_image

VI Partners

VI Partners investment in Post-IPO Equity - Kuros Biosciences

omega-funds_image

Omega Funds

Omega Funds investment in Post-IPO Equity - Kuros Biosciences

swiss-helvetia-fund_image

Swiss Helvetia Fund

Swiss Helvetia Fund investment in Post-IPO Equity - Kuros Biosciences

cdc-enterprises-2_image

CDC Enterprises

CDC Enterprises investment in Post-IPO Equity - Kuros Biosciences

neomed-management_image

Neomed Management

Neomed Management investment in Post-IPO Equity - Kuros Biosciences

defi-gestion_image

DEFI Gestion

DEFI Gestion investment in Post-IPO Equity - Kuros Biosciences

vinci-capital_image

VINCI CAPITAL

VINCI CAPITAL investment in Post-IPO Equity - Kuros Biosciences

vi-partners_image

VI Partners

VI Partners investment in Post-IPO Equity - Kuros Biosciences

Official Site Inspections

http://www.kuros.ch

  • Host name: 109.75.164.135
  • IP address: 109.75.164.135
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Kuros Biosciences" on Search Engine